# Zhejiang Doyin Pump Industry completes reverse merger with Shandong Luoxin Pharmaceutical

Zhejiang Doyin Pump Industry agreed in April 2019 to acquire Shandong Luoxin Pharmaceutical through a reverse merger valued at CNY 7.5 billion. The deal was reported as completed at the end of 2019.

- Type: Acquisition
- Announced: 2019-04-24
- Where: China
- Value: $1.07B (7.50B CNY)
- Status: completed

## Companies

- [Zhejiang Doyin Pump Industry](https://endata.com/companies/5953.md) (acquirer)
- [Shandong Luoxin Pharmaceutical](https://endata.com/companies/5954.md) (target)

## Sources

- [in.marketscreener.com](https://in.marketscreener.com/quote/stock/LUOXIN-PHARMACEUTICALS-GR-44292415/news/Shandong-Luoxin-Pharmaceutical-Group-Stock-Co-Ltd-completed-the-acquisition-of-Zhejiang-Doyin-Pum-34032764/), 2019-12-30: "Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. agreed to acquire Zhejiang Doyin Pump Industry Co.,Ltd. (SZSE:002793) in a reverse merger transaction on April 24, 2019."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.